From CRISPR to Synthetic Biology, Genomics to De-extinction – A Journey through the Cutting-Edge Advancements Shaping our Future
Written by
Dr. Deepak Sharma
BHMS, MD, Ph.D. (Scholar)
Homeopathic Physician and Educator
Founder – Orbit Clinics (World Class Homeopathic Clinics Worldwide)
Introduction:
Genetic engineering, once confined to the realms of science fiction, has taken rapid strides over the past few decades. It is revolutionizing how we tackle disease, improve crop yields, and even bring extinct species back to life. Through this post, we will delve into the recent advances in this exciting field, which encompasses techniques like CRISPR, gene therapy, and genomics.
Understanding Genetic Engineering:
In simple terms, genetic engineering is a set of technologies used to manipulate an organism’s genetic material or DNA to produce specific biological products or to alter the genes themselves. This transformative science has extensive applications, ranging from agriculture and medicine to industrial biotechnology.
CRISPR: A Revolution in Gene Editing
CRISPR-Cas9 has made gene editing almost as simple as cut-and-paste. Named for its unique sequence of DNA, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) works with an enzyme, Cas9, to cut DNA at precise locations, allowing scientists to add, delete, or alter specific genes.
After being discovered in bacteria in 2012, CRISPR technology has been quickly adopted due to its relative simplicity, efficiency, and cost-effectiveness. Recently, scientists have made major leaps in improving CRISPR’s precision, reducing off-target effects and potential for unintended mutations.
Moreover, the emergence of a new CRISPR system, CRISPR-Cas12a, is being explored. Cas12a differs from Cas9 by creating staggered cuts in the DNA, which could potentially improve repair efficiency and result in fewer off-target effects.
Gene Therapy: A Hope for Genetic Diseases
Gene therapy, another genetic engineering marvel, introduces, alters, or suppresses a gene to treat disease at its molecular root. Recent years have seen remarkable progress in this field.
In 2021, the FDA approved the first gene therapy for an inherited disease – a form of blindness caused by a mutation in the RPE65 gene. Scientists used a harmless virus to carry a correct version of the gene into patients’ cells, leading to significant improvements in vision.
Researchers are currently exploring gene therapy for treating diseases like hemophilia, certain cancers, and genetic conditions like cystic fibrosis and Duchenne muscular dystrophy. The hope is that a one-time gene therapy treatment could potentially cure these diseases.
Genomics: Decoding the Blueprint of Life
Genomics, the study of the complete set of genes within an organism, is another arena where rapid advances are being made. New sequencing technologies, like Next Generation Sequencing (NGS) and Third Generation Sequencing (TGS), have drastically reduced costs and increased speed and accuracy of genome sequencing.
Personalized medicine, fuelled by genomics, is becoming increasingly viable. The concept hinges on understanding an individual’s unique genetic makeup and tailoring treatment accordingly. For example, certain genes are now known to affect how an individual responds to specific drugs. By sequencing a patient’s genome, doctors can make informed decisions about the best treatments.
Furthermore, genomics is making strides in the field of oncology, with the development of CAR-T therapies. These genetically engineered T cells are modified to target specific cancer cells based on their genetic markers, offering new hope for cancer treatment.
The Road Ahead:
Despite the promising advances, genetic engineering is not without controversy or challenges. Ethical issues around genetic modification of humans, potential ecological impact, and the fear of ‘designer babies’ are among the concerns that need to be addressed. Furthermore, practical issues like the high cost of gene therapies and the possibility of unintended off-target effects continue to pose challenges.
Nevertheless, the advances in genetic engineering offer unprecedented possibilities. The technology could help us cure previously untreatable diseases, enhance our food supply, and address some of the most pressing environmental issues. As we continue to develop these tools, we must ensure that they are used responsibly and ethically, leveraging them for the betterment of all.
Synthetic Biology: Engineering Life from Scratch
Synthetic biology is a field closely tied to genetic engineering, wherein scientists take the principle of genetic manipulation to the next level. Synthetic biologists design and construct new biological parts, devices, and systems or redesign existing ones for useful purposes.
The most ambitious project in this field, to date, is the Synthetic Yeast 2.0 project. Completed in 2021, scientists successfully created a fully synthetic yeast genome, marking the first time a complex organism’s genome was built from scratch. This landmark achievement offers countless opportunities for understanding life processes and creating bio-based solutions to real-world problems.
Moreover, synthetic biology holds enormous promise in biomanufacturing. Through genetic modification, microorganisms like bacteria and yeast can be engineered to produce useful products, from biofuels and bioplastics to medicines and industrial chemicals. Synthetic biology is seen as a key technology to achieve a sustainable, bio-based economy.
De-extinction and Genetic Rescue:
In an astonishing twist of science, genetic engineering is now being employed in efforts to revive extinct species—a process known as de-extinction. This involves extracting DNA from preserved specimens of the extinct species and using it to create embryos that can be carried to term by a closely related species.
Recently, scientists have taken steps towards bringing back the woolly mammoth, a species that went extinct 4,000 years ago. By comparing the mammoth genome to that of its closest living relative, the Asian elephant, researchers aim to create a hybrid elephant-mammoth embryo using CRISPR to introduce mammoth traits into elephant cells.
Furthermore, genetic engineering is also being used for ‘genetic rescue’ of endangered species by correcting harmful mutations in their gene pool, strengthening their resistance to disease, and increasing their genetic diversity.
Regulation and Ethics: Balancing Innovation and Responsibility
As the capabilities of genetic engineering expand, the ethical and regulatory challenges also increase. Who decides what changes are acceptable or who can access these technologies? How do we prevent the misuse of this technology in the creation of bioweapons or unregulated genetically modified organisms?
For instance, the advent of gene drives, a technique that promotes the inheritance of a particular gene to increase its prevalence in a population, has raised alarms due to its potential to rapidly alter entire species and ecosystems.
To manage these challenges, a combination of public discourse, transparent scientific reporting, robust regulatory oversight, and international cooperation is required. As this technology evolves, society and policy must strive to keep pace, fostering an environment that supports both scientific innovation and ethical responsibility.
Genetic Privacy and Data Security: The Hidden Challenges
With the rapidly growing use of genomics and genetic engineering in medicine, an emerging challenge is the protection of genetic privacy and data security. Our DNA contains intimate information about us, including our susceptibility to certain diseases and, to some extent, our behaviors and traits. As more genetic data is collected and used, it’s crucial that this information is stored securely and that privacy is maintained.
This challenge is not merely a theoretical one. In recent years, there have been instances of genetic data being used to track individuals, and concerns have been raised about genetic discrimination by employers or insurers. Furthermore, large-scale genomic databases could potentially be targeted by cyberattacks. Regulations like the Genetic Information Nondiscrimination Act (GINA) in the U.S. aim to protect individuals, but we need a global, concerted effort to handle these concerns as genetic engineering becomes more commonplace.
Genetic Engineering in India: The Scope and Regulatory Landscape
In India, the potential of genetic engineering is widely recognized, and strides are being taken to harness this powerful technology across several sectors.
Agriculture and Biotechnology:
In agriculture, genetically modified (GM) crops such as Bt cotton have seen widespread adoption. This cotton variety, engineered to produce a toxin lethal to bollworms, has significantly improved yields and reduced pesticide usage. Moreover, other genetically engineered crops, including brinjal and mustard, have been evaluated and await government approval.
Biotechnology is another sector where genetic engineering is being actively pursued. Indian biotech companies are involved in producing genetically modified microorganisms used in the production of enzymes, biofuels, and pharmaceuticals.
Healthcare:
In healthcare, Indian researchers are engaged in exploring gene therapy for various genetic disorders and cancers. For example, the Centre for Cellular and Molecular Biology in Hyderabad is working on gene therapy for Thalassemia, a severe blood disorder.
India has also been a forerunner in the use of genomics for personalized medicine. With one of the most diverse gene pools in the world, India is leveraging genomic studies for understanding disease predisposition and drug response in its population.
Regulatory Framework:
The regulation of genetic engineering in India is governed by the rules of the Environment Protection Act (1986), administered by the Ministry of Environment, Forest and Climate Change. The Genetic Engineering Appraisal Committee (GEAC) is the apex body for approving activities involving large-scale use of genetically engineered organisms and products.
The Indian government, recognizing the potential of genetic engineering, has also laid out guidelines for gene therapy product development and clinical trials. The Central Drugs Standard Control Organization (CDSCO) under the Ministry of Health and Family Welfare is the national regulatory authority for monitoring gene therapeutic drugs.
However, the regulatory environment for genetic engineering in India has been marked by caution. There have been contentious debates over the approval of GM crops. Similarly, gene therapy in India is still primarily in the research phase, with stringent regulations for clinical trials.
Top 10 Colleges for Genetic Engineering in India:
For those interested in entering this groundbreaking field, here are the top ten colleges for genetic engineering in India that provide excellent education and research opportunities.
- Indian Institute of Technology (IIT), Delhi: The IIT in Delhi is one of the premier institutions in India, offering a variety of courses and research opportunities in biotechnology and genetic engineering.
- Indian Institute of Science (IISc), Bangalore: This institute is renowned for its research in the field of genetic engineering and biotechnology. The Department of Biochemistry is particularly known for its work in genomics and molecular biology.
- Jawaharlal Nehru University (JNU), New Delhi: JNU’s School of Biotechnology offers a range of courses, including genetic engineering, genomics, and bioinformatics.
- University of Hyderabad, Hyderabad: The university’s Department of Biotechnology & Bioinformatics offers courses focused on molecular genetics, genomics, and genetic engineering.
- Indian Institute of Technology (IIT), Madras: IIT Madras has a strong Biotechnology department that offers courses in genetic engineering and genomics.
- National Institute of Immunology, New Delhi: This Institute offers a research program in various fields of immunology and genetics. It is well known for its extensive research and publications in genetic engineering.
- Rajiv Gandhi Centre for Biotechnology (RGCB), Thiruvananthapuram: RGCB offers a doctoral program in biotechnology with a focus on genetic engineering, molecular biology, and genomics.
- Anna University, Chennai: The Centre for Biotechnology at Anna University offers B.Tech and M.Tech programs in Biotechnology and Genetic Engineering.
- Amity University, Uttar Pradesh: Amity Institute of Biotechnology offers a B.Tech program in Genetic Engineering.
- SRM Institute of Science and Technology, Chennai: The Department of Genetic Engineering at SRM is well known for its focus on advanced genetic engineering, genomics, and synthetic biology.
These institutions are pioneering the way forward in genetic engineering in India. With the field’s potential and the growing interest in it, the opportunities for students in genetic engineering are endless.
The Future: Beyond 2023
With an eye to the future, the possibilities of genetic engineering are vast and thrilling. Novel techniques are constantly being developed. For instance, the use of base editing and prime editing, offshoots of CRISPR technology, offer even greater precision and fewer off-target effects compared to earlier methods.
Base editing allows scientists to convert one DNA base into another without making a double-strand break in the DNA molecule, potentially reducing unintended mutations. On the other hand, prime editing is a versatile tool that enables direct, targeted insertions, deletions, and all 12 possible base-to-base conversions without requiring double-strand breaks or donor DNA templates.
Another emerging field is xenobiology, which aims to create artificial life with an expanded genetic code. Researchers have successfully developed semi-synthetic organisms with additional, artificial nucleotides in their DNA, which could be used to create novel proteins and biological circuits.
The synthetic biology startup, Ginkgo Bioworks, is reprogramming organisms to produce useful products, such as biofuels, fragrances, and even a plant-based burger. In healthcare, genetic engineering is helping develop novel vaccines, as seen with the rapid development of mRNA vaccines for COVID-19 by BioNTech/Pfizer and Moderna.
Meanwhile, advancements in genomics and genetic data analysis are leading to the era of personalized and precision medicine. Companies like 23andMe and Ancestry.com provide genome sequencing services to individuals, giving them insight into their health risks, ancestry, and even traits. In the medical field, understanding a patient’s genetic makeup allows for more precise treatment strategies, marking a shift from a ‘one size fits all’ approach to a more personalized one.
In agriculture, gene editing is being used to create ‘climate-smart crops’ that are more resilient to climate change effects. The startup, Yield10 Bioscience, for instance, is using CRISPR to engineer plants that can capture and process carbon more efficiently, potentially mitigating the effects of global warming.
However, it is crucial to remember that with great power comes great responsibility. While these advancements bring immense potential, they also underscore the need for careful ethical consideration and robust regulatory oversight. The genetic engineering community, in collaboration with policymakers, ethicists, and the public, will need to navigate this promising but complex landscape to harness its benefits while minimizing potential risks and harms.
Genetic engineering is undoubtedly one of the most exciting fields of the 21st century. As we move forward, the continued responsible development and deployment of these technologies will undoubtedly transform society and the world as we know it.
In the words of Marie Curie, “Nothing in life is to be feared, it is only to be understood. Now is the time to understand more, so that we may fear less.” This sentiment perfectly encapsulates the journey of genetic engineering as we push the boundaries of understanding and capability in this incredible field.
Conclusion:
In conclusion, as we traverse the ever-evolving landscape of genetic engineering, we are witnessing a remarkable fusion of science, technology, and innovation that is revolutionizing our approach to many of the world’s most pressing challenges. With its extensive applications ranging from medicine and agriculture to environmental sustainability and data security, genetic engineering stands at the forefront of this scientific revolution.
As with any powerful technology, the field grapples with various ethical and regulatory challenges. It is imperative to balance the quest for innovation with a strong commitment to ethical standards, robust regulatory oversight, and public discourse to ensure the responsible and equitable use of these breakthroughs. The stakes are high, as the decisions we make today will shape the trajectory of genetic engineering and its impact on our future.
The journey of genetic engineering is reminiscent of the words of Marie Curie, “Nothing in life is to be feared, it is only to be understood. Now is the time to understand more, so that we may fear less.” It is this spirit of curiosity, understanding, and respect for the power of science that must guide our foray into the possibilities of genetic engineering.
As we look forward, the vision is clear – a world where the diseases that have plagued humanity for centuries are a thing of the past, where food scarcity and environmental crises are effectively mitigated, and where the quality of life is significantly improved for all. Genetic engineering offers a promising path to this future, and we are just beginning to understand its immense potential. The golden age of genetic engineering is truly upon us, and the opportunities it presents are as vast as our collective imagination.
References:
- Doudna, J. A., & Charpentier, E. (2014). The new frontier of genome engineering with CRISPR-Cas9. Science, 346(6213), 1258096. doi: 10.1126/science.1258096
- Maguire, A. M., Russell, S., Wellman, J. A., et al. (2018). Efficacy, safety, and durability of voretigene neparvovec-rzyl in RPE65 mutation-associated inherited retinal dystrophy: Results of phase 1 and 3 trials. Ophthalmology, 126(9), 1273-1285. doi: 10.1016/j.ophtha.2019.01.035
- National Human Genome Research Institute. (2021). What are the types of gene therapy? Retrieved from https://www.genome.gov/genetics-glossary/Gene-Therapy
- World Health Organization. (2022). Gene editing. Retrieved from https://www.who.int/health-topics/gene-editing
- Roden, C. A., & Gladitz, J. (2020). Next-generation sequencing: Basic principles and emerging technologies. The Journal of Investigative Dermatology, 140(4), e9-e11. doi: 10.1016/j.jid.2019.10.029
- World Health Organization. (2019). Genomics. Retrieved from https://www.who.int/genomics/en/
- National Cancer Institute. (2021). CAR T-cell therapy: Engineering patients’ immune cells to treat their cancers. Retrieved from https://www.cancer.gov/about-cancer/treatment/research/car-t-cells
- Woolley, J. P., & Barrangou, R. (2020). The CRISPR Craze: A Critical Analysis. Trends in Microbiology, 28(9), 781-792. doi: 10.1016/j.tim.2020.05.001
- National Human Genome Research Institute. (2022). What are gene drives? Retrieved from https://www.genome.gov/genetics-glossary/Gene-Drive
- National Institutes of Health. (2021). Genetic Information Nondiscrimination Act (GINA). Retrieved from https://www.genome.gov/about-genomics/policy-issues/Genetic-Information-Nondiscrimination-Act
- Ministry of Environment, Forest and Climate Change. (n.d.). Genetic Engineering Appraisal Committee (GEAC). Retrieved from https://geacindia.gov.in/
- Central Drugs Standard Control Organization. (n.d.). Retrieved from https://cdsco.gov.in/
- Genetic Engineering and Biotechnology News. (2022). Synthetic Biology. Retrieved from https://www.genengnews.com/topics/omics/synthetic-biology/
- Kacar, B., & Gaucher, E. A. (2020). Towards xenobiology: Life with expanded genetic alphabet. Chemical Communications, 56(16), 2324-2335. doi: 10.1039/c9cc08401b
- Ginkgo Bioworks. (n.d.). Retrieved from https://www.ginkgobioworks.com/
- World Health Organization. (2022). Genomics and Global Health. Retrieved from https://www.who.int/genomics/global-health/en/
- Ramakrishna, S., Kwaku Dad, A. B., Beloor, J., et al. (2014). Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein and guide RNA. Genome Research, 24(6), 1020-1027. doi: 10.1101/gr.171264.113
- Kumar, A., & Srivastava, S. (2021). CRISPR prime editing: A new era of genome editing. Frontiers in Genome Editing, 3, 611205. doi: 10.3389/fgeed.2021.611205
- Huang, P., Xiao, A., Zhou, M., et al. (2021). Structural basis for RNA-guided DNA cleavage by Cas12a. Cell Research, 31(10), 1223-1225. doi: 10.1038/s41422-021-00516-y
- Liu, Y., Ma, Y., Xiang, Y., & Li, L. (2019). Applications of base editing in gene therapy and precision breeding of animals and plants. Cell & Bioscience, 9, 13. doi: 10.1186/s13578-019-0277-6
Top of Form
